不眠症治療のグローバル臨床試験動向(2014年H2)...市場調査レポートについてご紹介

【英文タイトル】Insomnia Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Insomnia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Insomnia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Insomnia to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Insomnia 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Insomnia Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Takeda Pharmaceutical Company Limited 34
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 34
Merck & Co., Inc. 37
Clinical Trial Overview of Merck & Co., Inc. 37
Dainippon Sumitomo Pharma Co., Ltd. 39
Clinical Trial Overview of Dainippon Sumitomo Pharma Co., Ltd. 39
Sanofi 41
Clinical Trial Overview of Sanofi 41
Neurocrine Biosciences, Inc. 43
Clinical Trial Overview of Neurocrine Biosciences, Inc. 43
Pfizer Inc. 45
Clinical Trial Overview of Pfizer Inc. 45
GlaxoSmithKline plc 47
Clinical Trial Overview of GlaxoSmithKline plc 47
Neurim Pharmaceuticals Ltd 48
Clinical Trial Overview of Neurim Pharmaceuticals Ltd 48
Eisai Co., Ltd. 49
Clinical Trial Overview of Eisai Co., Ltd. 49
Actelion Ltd 50
Clinical Trial Overview of Actelion Ltd 50
Clinical Trial Overview of Top Institutes / Government 51
University of Rochester 51
Clinical Trial Overview of University of Rochester 51
Duke University 52
Clinical Trial Overview of Duke University 52
U.S. Department of Veterans Affairs 53
Clinical Trial Overview of U.S. Department of Veterans Affairs 53
Karolinska Institute 54
Clinical Trial Overview of Karolinska Institute 54
University of Pittsburgh 55
Clinical Trial Overview of University of Pittsburgh 55
Brigham and Women’s Hospital 56
Clinical Trial Overview of Brigham and Women’s Hospital 56
Stanford University 57
Clinical Trial Overview of Stanford University 57
The University of Hong Kong 58
Clinical Trial Overview of The University of Hong Kong 58
Massachusetts General Hospital 59
Clinical Trial Overview of Massachusetts General Hospital 59
National Institute of Mental Health 60
Clinical Trial Overview of National Institute of Mental Health 60
Five Key Clinical Profiles 61
Appendix 108
Abbreviations 108
Definitions 108
Research Methodology 109
Secondary Research 109
About GlobalData 110
Contact Us 110
Disclaimer 110
Source 110


【レポート販売概要】

■ タイトル:不眠症治療のグローバル臨床試験動向(2014年H2)
■ 英文:Insomnia Global Clinical Trials Review, H2, 2014
■ 発行日:2014年7月14日
■ 調査会社:GlobalData
■ 商品コード:GDHC2236CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。